Clinical Trials

NCT07619599 | RECRUITING | PHASE1
6 participants

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-12
Start Date:
2026-09-14
Completion:
2028-12-22
Conditions
  • Metastatic Lung Non-Small Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Brain
  • Oligoprogressive Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
Interventions
  • PROCEDURE
  • RADIATION
  • BIOLOGICAL
No Results Yet
NCT07538609 | NOT_YET_RECRUITING | NA
150 participants

The GORE® VIABAHN® FORTEGRA Venous Stent Post-Approval Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-12
Start Date:
2026-10-07
Completion:
2029-05-31
Conditions
  • Venous Thromboses
  • Venous Disease
  • Venous Leg Ulcer
  • Venous Stasis
  • Venous Ulcer
  • Venous Stenosis
  • Venous Occlusion
  • Vein Thrombosis
Interventions
  • DEVICE
No Results Yet
NCT07538544 | NOT_YET_RECRUITING | EARLY_PHASE1
30 participants

MCE Molecular Imaging for ICI Myocarditis

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-12
Start Date:
2026-09-15
Completion:
2030-06-30
Conditions
  • Immune Checkpoint Inhibitor Myocarditis
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page